Introduction: Diabetic polyneuropathy (DPN) is the most common complication of diabetes, affecting nearly half of patients with type 2 diabetes. The aim of this study was to determine the prevalence and factors associated to DPN. Methods: We conducted a cross-sectional study from January to May 2024 at the Garoua Regional Hospital (GRH) and the Garoua General Hospital (HGG), involving type 2 diabetic patients. The DN-4 questionnaire, a screening tool for diabetic polyneuropathy comprising 10 items, was used as a diagnostic tool. The diagnosis was established based on a score ≥ 4. A logistic regression model was used to identify factors associated to DPN. The significance level was set at 5%. Results: Among the 203 patients included in the study, with a median (IQR) age of 56 (48 - 63) years, 68.5% were female. The median (IQR) duration of diabetes was 5 (2 - 9) years, with a median (IQR) glycated hemoglobin level of 8.80% (7.50% - 10.6%). Dyslipidemia was the most common additional cardiovascular risk factor (65.35%). The prevalence (95% CI) of painful diabetic neuropathy was 45.81% (38.82% - 52.96%). The main associated factors [aOR (95% CI), p] were female sex [3.65 (1.62 - 8.23), p = 0.037], age ≥ 60 years [4.57, (2.11 - 9.86), (p = 0.048)], diabetes duration ≥ 10 years [2.93. (1.16 - 7.45), (p = 0.006)], glycated hemoglobin level ≥ 7% [3.99, (1.25 - 5.72), (p = 0.043)] and chronic kidney disease [4.79, (2.22 - 7.54), (p = 0.009)]. Conclusion: The high prevalence of diabetic polyneuropathy and its multiple associated factors highlight a major challenge in its prevention, particularly through optimal glycaemic control, in order to improve patients’ quality of life.
Glovaci, D., Fan, W. and Wong, N.D. (2019) Epidemiology of Diabetes Mellitus and Cardiovascular Disease. CurrentCardiologyReports, 21, 21. https://doi.org/10.1007/s11886-019-1107-y
[3]
Lutte contre le diabète au Cameroun Riposte collective contre le tueur silencieux| MINSANTE. https://www.minsante.cm/site/?q=fr/content/lutte-contre-le-diab%C3%A8te-au-cameroun-riposte-collective-contre-le-tueur-silencieux
[4]
Elleuch, M., Hssine, H., Affes, L., Salah, B., Boujelbene, K.H., Khlif, R., et al. (2023) Prévalence et facteurs prédictifs de la polyneuropathie distale et symétrique diabétique. JIMSfax, 44, 38-42. https://www.medecinesfax.org/useruploads/files/Article6-44.pdf
[5]
Davies, M., Brophy, S., Williams, R. and Taylor, A. (2006) The Prevalence, Severity, and Impact of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes. DiabetesCare, 29, 1518-1522. https://doi.org/10.2337/dc05-2228
[6]
Owolabi, L.F., Alghamdi, M., Adamu, B., Taura, M.G., Jibo, A., Almansour, M., et al. (2022) Magnitude of Diabetic Peripheral Neuropathy in Saudi Arabia: A Systematic Review and Meta-Analysis. BMCEndocrineDisorders, 22, Article No. 266. https://doi.org/10.1186/s12902-022-01167-4
[7]
Dumont, I. (2011) Painful Diabetic Neuropathy: Diagnosis and Management. Diabetes & Metabolism. https://www.academia.edu/22790870/Painful_diabetic_neuropathy_Diagnosis_and_management
[8]
Aynaou, H. and Latrech, H. (2019) Neuropathie Diabétique Périphérique Au CHU Mohamed VI d’Oujda. IOSR-JDMS, 18, 64-68. https://www.iosrjournals.org/iosr-jdms/papers/Vol18-issue8/Series-5/M1808056468.pdf
[9]
Chahbi, Z., Lahmar, B., El Hadri, S., Abainou, L., Kaddouri, S., Qacif, H., et al. (2018) The Prevalence of Painful Diabetic Neuropathy in 300 Moroccan Diabetics. PanAfricanMedicalJournal, 31, Article No. 158. https://doi.org/10.11604/pamj.2018.31.158.14687
[10]
Simo, N., Kuate-Tegueu, C., Ngankou-Tchankeu, S., Doumbe, J., Maiga, Y., Cesari, M., et al. (2020) Correlates of Diabetic Polyneuropathy of the Elderly in Sub-Saharan Africa. PLOSONE, 15, e0240602. https://doi.org/10.1371/journal.pone.0240602
[11]
Dehayem Yefou, M., Sobngwi, E., Nwatsock, J.F., Maka Mani, J., Jupkwo, B. and Mbanya, J.C. (2010) P86 Prise en charge du diabète sucré au Cameroun: Résultats de l’étude Diabcare. Diabetes&Metabolism, 36, A59-A60. https://doi.org/10.1016/s1262-3636(10)70234-2
[12]
Sonafouo, D.V., Kamguia, L., Endomba, T., Chetcha, B., Sobngwi, E., Mbanya, J.C., et al. (2018) Neuropathie diabétique et facteurs associés dans une population de patients diabétiques de type 1 au cameroun. Société francophone du diabète. https://www.researchgate.net/publication/324784044_EP-132_Neuropathie_diabetique_et_facteurs_associes_dans_une_population_de_patients_diabetiques_de_type_1_au_Cameroun
[13]
Spallone, V., Morganti, R., D’Amato, C., Greco, C., Cacciotti, L. and Marfia, G.A. (2012) Validation of DN4 as a Screening Tool for Neuropathic Pain in Painful Diabetic Polyneuropathy. DiabeticMedicine, 29, 578-585. https://doi.org/10.1111/j.1464-5491.2011.03500.x
[14]
Mojaddidi, M.A., Aboonq, M., Al Nozha, O.M., Allam, A. and Fath El-Bab, M. (2011) Early Diagnosis of Diabetic Neuropathy in Almadinah Almunawwarah. JournalofTaibahUniversityMedicalSciences, 6, 121-131. https://doi.org/10.1016/s1658-3612(11)70173-1
[15]
Hode, A.K., Dedjan, H. and Sondjo, F.M. (2023) Peripheral Neuropathy and Associated Factors in Diabetics at the CNHU-HKM of Cotonou in 2021. JournalofDiabetesMellitus, 13, 12-22. https://doi.org/10.4236/jdm.2023.131002
[16]
Halawa, M.R., Karawagh, A., Zeidan, A., Mahmoud, A.H., Sakr, M. and Hegazy, A. (2009) Prevalence of Painful Diabetic Peripheral Neuropathy among Patients Suffering from Diabetes Mellitus in Saudi Arabia. CurrentMedicalResearchandOpinion, 26, 337-343. https://doi.org/10.1185/03007990903471940
[17]
Sani, M.A.M., Djibo, I.M. Andia, A., Madougou, S., Brah, S., Beydou, S.S., et al. (2015) Facteurs associés à la neuropathie diabétique à l’Hôpital National de Lamordé (Niamey-Niger). Health Sciences and Disease, 16, 546. https://www.hsd-fmsb.org/index.php/hsd/article/view/546
[18]
Brown, M.J. and Asbury, A.K. (1984) Diabetic Neuropathy. AnnalsofNeurology, 15, 2-12. https://doi.org/10.1002/ana.410150103
[19]
Bassanguen, P., Ewane, M.E., Doumbè, J. and Adiogo, D. (2019) Evaluation de la neuropathie par le vibrocheck chez le diabétique à l’hôpital général de Douala. Yaoundé Congres Hall. OERF035. https://tropical-cardiology.com/Accueil/index.php/2013-08-10-06-44-55/n-special-151-jan-fev-mars-2018/304-p4-evaluation-de-la-neuropathie-par-le-vibrocheck-chez-le-diabetique-a-l-hopital-general-de-douala